OS-01 for Cellular Senescence & Skin Anti-Aging — Skin & Hair

Senolytic peptide for removing senescent cells, reducing cellular aging, and improving skin health and healthy aging.

Overview

OS-01 (Oligopeptide-01) is a novel senolytic peptide developed through AI-driven drug discovery that selectively targets and clears senescent cells (zombie cells) in aging skin. Senescent cells accumulate with age and contribute to inflammation, tissue dysfunction, and visible aging. OS-01 works by inducing apoptosis in senescent fibroblasts while preserving healthy cells. Clinical studies show improvements in skin barrier function, reduced inflammation, and enhanced cellular turnover. Represents a cutting-edge approach to anti-aging by addressing root causes rather than symptoms.

Indications

  • Cellular senescence and skin aging
  • Chronic inflammation and inflammaging
  • UV-damaged and photoaged skin
  • Age-related skin barrier dysfunction
  • Loss of skin elasticity and firmness
  • Cellular turnover optimization
  • Prevention of age-related decline

Mechanism of Action

Aging and UV damage cause accumulation of zombie cells that resist apoptosis and secrete inflammatory factors

Dosing

CompoundDoseFrequencyNotes
OS-01 PeptideApply 2-3 dropsOnce daily (evening preferred)Apply to clean skin before moisturizer
OS-01 Peptide3-4 dropsOnce daily (evening)Extended application for comprehensive anti-aging
OS-01 + Retinol 0.25-0.5%Alternate nights or layerAs toleratedSynergistic cellular turnover, start slowly to assess tolerance
OS-01 PeptideAs directedAfter microneedling or laserEnhanced penetration post-treatment, may accelerate healing

Safety & Contraindications

  • Novel peptide with limited long-term human data
  • Generally well-tolerated in clinical trials to date
  • Patch test recommended before full facial application
  • May cause mild irritation or redness in sensitive skin
  • Avoid combining with other strong actives initially
  • Discontinue if persistent irritation occurs
  • Pregnant or nursing women should consult physician